The findings reported in this study of fascin-activating β-catenin signaling through FAK and the subsequent effect of this signaling cascade on CSC function present a feasible window for therapeutic targeting of fascin-FAK-β-catenin axis in order to effectively exterminate the core of cancer. This evidence concerns the gene PTK2 and cancer.